Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD)
- DOI
- 10.3390/diagnostics15212723
- Published
- 2025-10-27
- Container
- Diagnostics
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/diagnostics15212723,
title = {Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD)},
author = {Koichi Kimura and Koji Hayashi and Mamiko Sato and Yuka Nakaya and Asuka Suzuki and Naoko Takaku and Hiromi Hayashi and Kouji Hayashi and Toyoaki Miura and Yasutaka Kobayashi},
year = {2025},
journal = {Diagnostics},
doi = {10.3390/diagnostics15212723},
url = {https://doi.org/10.3390/diagnostics15212723}
}RIS
TY - JOUR TI - Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD) AU - Koichi Kimura AU - Koji Hayashi AU - Mamiko Sato AU - Yuka Nakaya AU - Asuka Suzuki AU - Naoko Takaku AU - Hiromi Hayashi AU - Kouji Hayashi AU - Toyoaki Miura AU - Yasutaka Kobayashi PY - 2025 JO - Diagnostics DO - 10.3390/diagnostics15212723 UR - https://doi.org/10.3390/diagnostics15212723 ER -
APA
Kimura, K., Hayashi, K., Sato, M., Nakaya, Y., Suzuki, A., Takaku, N., Hayashi, H., Hayashi, K., Miura, T., & Kobayashi, Y. (2025). Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD). Diagnostics. https://doi.org/10.3390/diagnostics15212723
Source records
- crossref · retrieved 2026-11-09T14:59:41.778Z